Perlegen Sciences files to withdraw $115 mln IPO

WASHINGTON May 1 (Reuters) - Biopharmaceutical company Perlegen Sciences Inc. filed with regulators on Tuesday to withdraw its plans to raise up to $115 million in an initial public offering of common stock.

Perlegen said in a filing with the U.S. Securities and Exchange Commission that its withdrawal of the IPO was "consistent with the public interest and the protection of investors."

The company had planned to have Lehman Brothers, Deutsche Bank Securities, Piper Jaffray and Allen & Co. LLC underwrite the IPO and to list its stock on the Nasdaq under the symbol "PERL." PERL.O